Skip to main content
Figure 2 | Stem Cell Research & Therapy

Figure 2

From: Reductions in behavioral deficits and neuropathology in the R6/2 mouse model of Huntington’s disease following transplantation of bone-marrow-derived mesenchymal stem cells is dependent on passage number

Figure 2

In vitro quantitative RT-PCR of brain-derived neurotrophic factor mRNA expression of bone marrow mesenchymal stem cells. A significant increase in mRNA levels of brain-derived neurotrophic factor (BDNF) was observed in the high-passaged bone marrow mesenchymal stem cells (BM MSCs) compared with low-passaged BM MSCs. †Significant from high-passage BM MSCs; tail-tip fibroblasts (TTF) are control cDNA isolated from mice. Bar graph represents mean value; error bars represent standard error of the mean.

Back to article page

Stem Cell Research & Therapy

ISSN: 1757-6512